Biosyent (TSXV:RX) Price-to-Operating-Cash-Flow : 15.66 (As of May. 23, 2024)

View and export this data going back to 1979. Start your Free Trial

What is Biosyent Price-to-Operating-Cash-Flow?

As of today (2024-05-23), Biosyent's share price is C$9.19. Biosyent's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was C$0.59. Hence, Biosyent's Price-to-Operating-Cash-Flow Ratio for today is 15.66.

The historical rank and industry rank for Biosyent's Price-to-Operating-Cash-Flow or its related term are showing as below:

TSXV:RX' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 9.8 Med: 22 Max: 80.7
Current: 15.33

During the past 13 years, Biosyent's highest Price-to-Operating-Cash-Flow Ratio was 80.70. The lowest was 9.80. And the median was 22.00.

TSXV:RX's Price-to-Operating-Cash-Flow is ranked better than
55.01% of 678 companies
in the Drug Manufacturers industry
Industry Median: 17.245 vs TSXV:RX: 15.33

Biosyent's Cash Flow from Operations per share for the three months ended in Mar. 2024 was C$0.08. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was C$0.59.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Biosyent was 85.20% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -7.70% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 0.20% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 9.00% per year.

During the past 13 years, Biosyent's highest 3-Year average Operating Cash Flow per Share Growth Rate was 267.60% per year. The lowest was -60.70% per year. And the median was 26.70% per year.

Biosyent Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Biosyent's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosyent Price-to-Operating-Cash-Flow Chart

Biosyent Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

19.30

15.01

22.75

17.72

22.22

Biosyent Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															23.66	17.06	14.59	22.22	14.82

Competitive Comparison of Biosyent's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Biosyent's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biosyent's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Biosyent's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Biosyent's Price-to-Operating-Cash-Flow falls into.

Biosyent Price-to-Operating-Cash-Flow Calculation

Biosyent's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	9.19	/	0.587
	=	15.66

Biosyent's Share Price of today is C$9.19.
Biosyent's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.59.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Biosyent Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Biosyent's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Biosyent (TSXV:RX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biosyent Inc (TSXV:RX) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

BIOYF:USA

Address

2476 Argentia Road, Suite 402, Toronto, Mississauga, ON, CAN, L5N 6M1

Website

http://www.biosyent.com

Biosyent Inc is a Canada-based growth-oriented specialty pharmaceutical company. It has focused on in-licensing or acquiring originative pharmaceuticals and other healthcare products. Its product includes FeraMAX 150, Cathejell Jelly, FeraMAX Powder, RepaGyn, Proktis-M, Repagyn, and Tibella.

Executives

Peter Douglas Lockhard

Director

Biosyent (TSXV:RX) Headlines

No Headlines